CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) |
Total |
Series A Preferred Stocks |
Series E Preferred Stocks |
Common Stock |
Preferred Stock |
Paid In Capital |
Treasury Stock |
Other Comp Income |
Accumulated Deficit |
---|---|---|---|---|---|---|---|---|---|
Balance, shares at Dec. 31, 2022 | 1,000 | 22,246,654 | 1 | 12,180 | |||||
Balance, amount at Dec. 31, 2022 | $ 13,192,141 | $ 1 | $ 222,467 | $ 40,000 | $ 56,889,031 | $ (34,773) | $ 112,078 | $ (44,036,663) | |
Issuance of Common Stock, shares | 1,000,000 | ||||||||
Issuance of Common Stock, amount | 5,000,000 | $ 10,000 | 4,990,000 | ||||||
Issuance of Non-Dilution Shares, shares | 125,054 | ||||||||
Issuance of Non-Dilution Shares, amount | $ 1,250 | (1,250) | |||||||
Stock Compensation - Vesting | 881,250 | 881,250 | |||||||
Purchase of Series A Stock, shares | 1,000 | ||||||||
Purchase of Series A Stock, amount | (1,250,000) | $ (1,250,000) | |||||||
Cancellation of Series A Stock, shares | (1,000) | (1,000) | |||||||
Cancellation of Series A Stock, amount | $ (1) | (1,249,999) | $ 1,250,000 | ||||||
Acquisition of Treasury Stock, shares | 25,000 | ||||||||
Acquisition of Treasury Stock, amount | (60,250) | $ (60,250) | |||||||
Other Comprehensive Income | 585,622 | 585,622 | |||||||
Net Loss | (14,533,504) | (14,533,504) | |||||||
Balance, shares at Dec. 31, 2023 | 23,371,708 | 1 | 37,180 | ||||||
Balance, amount at Dec. 31, 2023 | 3,815,259 | $ 233,717 | $ 40,000 | 61,509,032 | $ (95,023) | 697,700 | (58,570,167) | ||
Issuance of Common Stock, shares | 5,769,231 | ||||||||
Issuance of Common Stock, amount | 6,000,000 | $ 57,692 | 5,942,308 | ||||||
Sales of Series E Preferred Shares | 1,552,795 | ||||||||
Sales of Series E Preferred Shares, Amount | 2,500,000 | $ 2,500,000 | |||||||
Sales Issued for Services, Shares | 287,287 | ||||||||
Sales Issued for Services, Value | 462,532 | $ 2,873 | 459,659 | ||||||
Stock Compensation - Vesting | 1,219,062 | 1,219,062 | |||||||
Cancellation of Shares | (112,500) | ||||||||
Cancellation of Shares, amount | $ (1,125) | 1,125 | |||||||
Other Comprehensive Income | (2,486,399) | (2,486,399) | |||||||
Net Loss | (8,134,852) | (8,134,852) | |||||||
Balance, shares at Dec. 31, 2024 | 1,552,795 | 29,315,726 | 1 | 37,180 | |||||
Balance, amount at Dec. 31, 2024 | $ 3,375,602 | $ 2,500,000 | $ 293,157 | $ 40,000 | $ 69,131,186 | $ (95,023) | $ (1,788,699) | $ (66,705,019) |
X | ||||||||||
- Definition Acquisition of treasury stock amount. No definition available.
|
X | ||||||||||
- Definition Acquisition of treasury stock shares. No definition available.
|
X | ||||||||||
- Definition Cancellation of Series A stock amount. No definition available.
|
X | ||||||||||
- Definition Cancellation of Series A stock shares. No definition available.
|
X | ||||||||||
- Definition Cancellation of shares No definition available.
|
X | ||||||||||
- Definition Cancellation of shares amount. No definition available.
|
X | ||||||||||
- Definition Purchase of Series A stock amount. No definition available.
|
X | ||||||||||
- Definition Purchase of Series A stock shares. No definition available.
|
X | ||||||||||
- Definition Sales of series E preferred shares. No definition available.
|
X | ||||||||||
- Definition Sales of series E preferred shares, amount. No definition available.
|
X | ||||||||||
- Definition Stock issued during period share issuance of non-dilution shares. No definition available.
|
X | ||||||||||
- Definition Stock issued during period value issuance of non-dilution shares. No definition available.
|
X | ||||||||||
- Definition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of tax expense (benefit) allocated to other comprehensive income (loss). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders. No definition available.
|
X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders. No definition available.
|
X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|